Therapeutic Area Strategy Head, CRM
Novartis AG
Basel (City)
Key information
- Publication date:22 January 2026
- Workload:100%
- Place of work:Basel (City)
Summary
Location: Basel, Switzerland.
Please note, this role can be based in Basel, Switzerland or in the US. If you are based in the US, please apply via REQ-10069549.
The Therapeutic Area Strategy Head will lead a therapeutic area focused team in the creation and ongoing update of a holistic and aligned Enterprise portfolio strategy for their Therapeutic Area (TA). The candidate will work closely with the senior leaders within the cardio-renal-metabolic (CRM) TA including Bio-medical Research (BR), Development and Commercial organizations in US and International and Search & Evaluation. The candidate will bring a passion for innovation, deep industry experience, scientific acumen and strong judgement to guide internal choices and drive sustainable growth in the short, mid and long-term in CRM. This individual will have both a broad and deep understanding of the CRM field to drive insightful and differentiating competitive advantages over our peers by bringing a third-party view around key strategic levers and external analyses, trends, and white space opportunities. Additionally, they will conduct targeted primary research.
About the Role
Key Responsibilities:
Provides external perspective and identifies opportunities:
- Builds and maintains in-depth knowledge of the TA (early pipeline to commercial); including disease models; responsible for ongoing assessment of peer companies with heavy exposure in the TA.
- Educates, updates and provides external views to all internal stakeholders. Provides insight within key portfolio governance processes (diligence and external landscape mapping with BD&L and M&A)
- Supports identification of growth accretive opportunities, indications, disease spaces and rejection of low value opportunities/projects
- Supports Group Investor Relations and the CEO Office with dissemination of key strategic insights
- Ongoing collection and synthesis of scientific and commercial insights for the TA
Owns TA portfolio strategy and prioritization:
- Leads the process of creating, maintaining and updating enterprise-wide TA portfolio strategy, including disease area and molecule selection to drive mid- and long-term growth in collaboration with RDC
- Identifies potential pipeline gaps, makes recommendations to address
- Works closely with key stakeholders in the Therapeutic Area Leadership (TAL) team to facilitate portfolio decision making, prioritization and trade-offs
Internal and External Commercial and Pipeline Modelling:
- Oversees assessments of programs fit to current portfolio strategy and facilitates central review for assets inside and outside current priorities (e.g., at Innovation Management Board (IMB))
- Provides consolidated commercial and development inputs to support business cases for internal and external assets and programs
- Provides outside-in independent view of internal assumptions around core pipeline
- Leads the development of assessment of external opportunities (e.g., forecast assumptions, business cases)
Others:
- Coaches, attracts, develops, and retains top talents; partners with P&O leadership to develop people strategy (e.g. organization development, performance, career development).
- Plans, allocates, and manages TA strategy financial budget by anticipating expenditures, accurately forecasting resource needs/costs and properly accounting for expenses to meet requirements and achieve fiscal responsibility
Essential Requirements:
- Advanced degree or equivalent experience in life science/healthcare required, Cardiologist training highly desirable
- Demonstrated cross‑functional global leadership experience is essential.
- Minimum 10 years of pharmaceutical/biotech experience gained in banking, consulting, or biopharma, with exposure to drug development and ideally commercialization required. Proven ability to operate effectively in a highly matrixed, fast paced environment.
- Candidates with significant senior leadership experience — including Biotech CEOs and executives from investment banking or other Wall Street institutions are strongly preferred
- Ability to comfortably engage with the C-suite and mid-career associates to influence and challenge with excellent interpersonal and leadership skills
- Strong financial and business acumen with strong understanding of biopharma landscape; companies, assets and early technologies
- Strong strategic vision, superior leadership, excellent communication, consensus building, and well-developed influencing and negotiation skills
- Excellent conflict resolution skills to facilitate agreement and buy-in at the senior-most levels
- Experience leading and managing a team with a variety of insights from science to commercial and proven coaching and mentoring experience
Commitment to Diversity and Inclusion:
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Accessibility and Accommodation:
Novartis is committed to working with and providing reasonable accommodation to all individuals. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in order to receive more detailed information about the essential functions of a position, please send an e-mail to E-Mail schreiben and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Benefits and Rewards: Learn about all the ways we’ll help you thrive personally and professionally.
Read our handbook (PDF 30 MB)